Literature DB >> 26785156

How diagnostic tests help to disentangle the mechanisms underlying neuropathic pain symptoms in painful neuropathies.

Andrea Truini1, Giorgio Cruccu.   

Abstract

Neuropathic pain, ie, pain arising directly from a lesion or disease affecting the somatosensory afferent pathway, manifests with various symptoms, the commonest being ongoing burning pain, electrical shock-like sensations, and dynamic mechanical allodynia. Reliable insights into the mechanisms underlying neuropathic pain symptoms come from diagnostic tests documenting and quantifying somatosensory afferent pathway damage in patients with painful neuropathies. Neurophysiological investigation and skin biopsy studies suggest that ongoing burning pain primarily reflects spontaneous activity in nociceptive-fiber pathways. Electrical shock-like sensations presumably arise from high-frequency ectopic bursts generated in demyelinated, nonnociceptive, Aβ fibers. Although the mechanisms underlying dynamic mechanical allodynia remain debatable, normally innocuous stimuli might cause pain by activating spared and sensitized nociceptive afferents. Extending the mechanistic approach to neuropathic pain symptoms might advance targeted therapy for the individual patient and improve testing for new drugs.

Entities:  

Mesh:

Year:  2016        PMID: 26785156     DOI: 10.1097/j.pain.0000000000000367

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  7 in total

1.  CSF levels of apolipoprotein C1 and autotaxin found to associate with neuropathic pain and fibromyalgia.

Authors:  Anne-Li Lind; David Just; Maria Mikus; Claudia Fredolini; Marina Ioannou; Björn Gerdle; Bijar Ghafouri; Emmanuel Bäckryd; Lars Tanum; Torsten Gordh; Anna Månberg
Journal:  J Pain Res       Date:  2019-10-15       Impact factor: 3.133

2.  Dissecting central post-stroke pain: a controlled symptom-psychophysical characterization.

Authors:  Luciana Mendonça Barbosa; Valquíria Aparecida da Silva; Antônia Lilian de Lima Rodrigues; Diego Toledo Reis Mendes Fernandes; Rogério Adas Ayres de Oliveira; Ricardo Galhardoni; Lin Tchia Yeng; Jefferson Rosi Junior; Adriana Bastos Conforto; Leandro Tavares Lucato; Marcelo Delboni Lemos; Roland Peyron; Luis Garcia-Larrea; Manoel Jacobsen Teixeira; Daniel Ciampi de Andrade
Journal:  Brain Commun       Date:  2022-04-05

3.  Alcoholic neuropathy associated with chronic alcohol intake.

Authors:  Maria Eduarda Tessitore; Laís da Silva Pereira-Rufino; Carlos Eduardo Panfilio; Rita de Cassia Sinigaglia; Odair Aguiar Júnior; Luciana Le-Sueur Maluf; Rafael Conte; Fernando Vagner Lobo Ladd; Isabel Cristina Céspedes
Journal:  IBRO Neurosci Rep       Date:  2022-08-17

4.  Investigating the validity of the DN4 in a consecutive population of patients with chronic pain.

Authors:  Hans Timmerman; Monique A H Steegers; Frank J P M Huygen; Jelle J Goeman; Nick T van Dasselaar; Marcel J Schenkels; Oliver H G Wilder-Smith; André P Wolff; Kris C P Vissers
Journal:  PLoS One       Date:  2017-11-30       Impact factor: 3.240

5.  Quantification of small fiber pathology in patients with sarcoidosis and chronic pain using cornea confocal microscopy and skin biopsies.

Authors:  Linda Cj Oudejans; Marieke Niesters; Michael Brines; Albert Dahan; Monique van Velzen
Journal:  J Pain Res       Date:  2017-08-26       Impact factor: 3.133

6.  The added value of bedside examination and screening QST to improve neuropathic pain identification in patients with chronic pain.

Authors:  Hans Timmerman; Oliver Hg Wilder-Smith; Monique Ah Steegers; Kris Cp Vissers; André P Wolff
Journal:  J Pain Res       Date:  2018-07-10       Impact factor: 3.133

7.  Mitochondrial calcium uniporter deletion prevents painful diabetic neuropathy by restoring mitochondrial morphology and dynamics.

Authors:  Dale S George; Sandra Hackelberg; Nirupa D Jayaraj; Dongjun Ren; Seby L Edassery; Craig A Rathwell; Rachel E Miller; Anne-Marie Malfait; Jeffrey N Savas; Richard J Miller; Daniela M Menichella
Journal:  Pain       Date:  2022-03-01       Impact factor: 7.926

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.